Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Thymic stromal lymphopoietin expression from benign lymphoproliferation to malignant B-cell lymphoma in primary Sjögren's syndrome.

Gandolfo S, Bulfoni M, Fabro C, Russi S, Sansonno D, Di Loreto C, Cesselli D, De Vita S.

Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):55-64. Epub 2019 Aug 27.

2.

HCV RNA Genomic sequences and HCV-E2 glycoprotein in sural nerve biopsies from HCV-infected patients with peripheral neuropathy.

Russi S, Sansonno D, Monaco S, Mariotto S, Ferrari S, Pavone F, Lauletta G, Dammacco F.

Neuropathol Appl Neurobiol. 2018 Jun;44(4):427-438. doi: 10.1111/nan.12413. Epub 2017 Jun 22.

PMID:
28543916
3.

The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review.

Dammacco F, Racanelli V, Russi S, Sansonno D.

Clin Exp Med. 2016 Aug;16(3):233-42. doi: 10.1007/s10238-016-0410-9. Epub 2016 Mar 2. Review.

PMID:
26935415
4.

Hepatitis C Virus-Associated B-Cell Non-Hodgkin's Lymphoma: Clinical and Therapeutic Challenges.

Russi S, Sansonno L, Sansonno D.

Curr Drug Targets. 2017;18(7):766-771. doi: 10.2174/1389450117666160201112525. Review.

PMID:
26844565
5.

Autoimmune Hepatitis: Factors Involved in Initiation and Methods of Diagnosis and Treatment.

Lauletta G, Russi S, Pavone F, Marzullo A, Tampoia M, Sansonno D, Dammacco F.

Crit Rev Immunol. 2016;36(5):407-428. doi: 10.1615/CritRevImmunol.2017017868. Review.

PMID:
28605347
6.

Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015.

Monaco S, Mariotto S, Ferrari S, Calabrese M, Zanusso G, Gajofatto A, Sansonno D, Dammacco F.

World J Gastroenterol. 2015 Nov 14;21(42):11974-83. doi: 10.3748/wjg.v21.i42.11974. Review.

7.

Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients With Circulating Cryoglobulins.

Bellanti F, Lauletta G, Villani R, Lipsi MR, Natalicchio MI, Sansonno D, Vendemiale G, Serviddio G.

Medicine (Baltimore). 2015 Sep;94(35):e1409. doi: 10.1097/MD.0000000000001409.

8.

Activation-induced cytidine deaminase in B cells of hepatits C virus-related cryoglobulinaemic vasculitis.

Russi S, Dammacco F, Sansonno S, Pavone F, Sansonno D.

Clin Exp Immunol. 2015 Dec;182(3):323-31. doi: 10.1111/cei.12690. Epub 2015 Sep 17.

9.

[Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: final analysis of GIDEON study in Italy].

D'Angelo S, Germano D, Zolfino T, Sansonno D, Giannitrapani L, Benedetti A, Montesarchio V, Attili A, Buonadonna A, Barni S, Gasbarrini A, Burlone ME, Cillo U, Marenco S, Villa E, Giovanis P, Proserpio I, Saitta C, Magini G, Cengarle R, Fava G, Cuttone F, Calvani N, Angelico M, Di Costanzo F, Noto A, Poggi G, Marignani M, Cascinu S, Amoroso D, Palmieri V, Massa E, Crocè LS, Picardi A, Tumulo S, Erminero C, Lencioni R, Lorusso V.

Recenti Prog Med. 2015 May;106(5):217-26. doi: 10.1701/1868.20406. Italian.

PMID:
25994538
10.

Correction: Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases.

De Re V, Caggiari L, De Zorzi M, Repetto O, Zignego AL, Izzo F, Tornesello ML, Buonaguro FM, Mangia A, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Vaccher E, Beretta M, Mazzaro C, Libra M, Gini A, Zucchetto A, Cannizzaro R, De Paoli P.

PLoS One. 2015 May 15;10(5):e0128849. doi: 10.1371/journal.pone.0128849. eCollection 2015. No abstract available.

11.

Thymic stromal lymphopoietin in hepatitis C virus-related cryoglobulinemic vasculitis: gene expression level and protein distribution.

Sansonno D, Russi S, Sansonno S, Pavone F, Dammacco F.

Arthritis Res Ther. 2015 Mar 15;17:62. doi: 10.1186/s13075-015-0581-x.

12.

Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases.

De Re V, Caggiari L, De Zorzi M, Repetto O, Zignego AL, Izzo F, Tornesello ML, Buonaguro FM, Mangia A, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Vaccher E, Berretta M, Mazzaro C, Libra M, Gini A, Zucchetto A, Cannizzaro R, De Paoli P.

PLoS One. 2015 Feb 20;10(2):e0117420. doi: 10.1371/journal.pone.0117420. eCollection 2015. Erratum in: PLoS One. 2015;10(5):e0128849. Beretta, Massimiliano [corrected to Berretta, Massimiliano].

13.

Validation of the classification criteria for cryoglobulinaemic vasculitis.

Quartuccio L, Isola M, Corazza L, Ramos-Casals M, Retamozo S, Ragab GM, Zoheir MN, El-Menyawi MA, Salem MN, Sansonno D, Ferraccioli G, Gremese E, Tzioufas A, Voulgarelis M, Vassilopoulos D, Scarpato S, Pipitone N, Salvarani C, Guillevin L, Terrier B, Cacoub P, Filippini D, Saccardo F, Gabrielli A, Fraticelli P, Sebastiani M, Tomsic M, Tavoni A, Mazzaro C, Pioltelli P, Nishimoto N, Scaini P, Zignego AL, Ferri C, Monti G, Pietrogrande M, Bombardieri S, Galli M, De Vita S.

Rheumatology (Oxford). 2014 Dec;53(12):2209-13. doi: 10.1093/rheumatology/keu271. Epub 2014 Jul 3.

PMID:
24994905
14.

Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection.

De Re V, Gragnani L, Fognani E, Piluso A, Izzo F, Mangia A, Crovatto M, Gava G, Casarin P, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Caggiari L, De Zorzi M, Berretta M, Gini A, Zucchetto A, Buonaguro FM, De Paoli P, Zignego AL.

Biomed Res Int. 2014;2014:710642. doi: 10.1155/2014/710642. Epub 2014 Feb 26.

15.

Assessment of total hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia.

Russi S, Sansonno D, Mariggiò MA, Vinella A, Pavone F, Lauletta G, Sansonno S, Dammacco F.

Arthritis Res Ther. 2014 Mar 18;16(2):R73. doi: 10.1186/ar4513.

16.

Interleukin 28B gene polymorphisms in hepatitis C virus-related cryoglobulinemic vasculitis.

Sansonno D, Russi S, Serviddio G, Conteduca V, D'Andrea G, Sansonno L, Pavone F, Lauletta G, Mariggiò MA, Dammacco F.

J Rheumatol. 2014 Jan;41(1):91-8. doi: 10.3899/jrheum.130527. Epub 2013 Dec 1.

PMID:
24293567
17.

Therapy for hepatitis C virus-related cryoglobulinemic vasculitis.

Dammacco F, Sansonno D.

N Engl J Med. 2013 Sep 12;369(11):1035-45. doi: 10.1056/NEJMra1208642. Review. No abstract available.

PMID:
24024840
18.

Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents.

Conteduca V, Sansonno D, Russi S, Pavone F, Dammacco F.

J Infect. 2014 Jan;68(1):1-20. doi: 10.1016/j.jinf.2013.08.019. Epub 2013 Sep 4. Review.

PMID:
24012819
19.

Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective Study.

Lauletta G, Russi S, Conteduca V, Sansonno L, Dammacco F, Sansonno D.

Medicine (Baltimore). 2013 Sep;92(5):245-256. doi: 10.1097/MD.0b013e31829d2abc.

20.

Precancerous colorectal lesions (Review).

Conteduca V, Sansonno D, Russi S, Dammacco F.

Int J Oncol. 2013 Oct;43(4):973-84. doi: 10.3892/ijo.2013.2041. Epub 2013 Jul 29. Review.

PMID:
23900573
21.

Multidisciplinary approach for HCC patients: hepatology for the oncologists.

Barone C, Koeberle D, Metselaar H, Parisi G, Sansonno D, Spinzi G.

Ann Oncol. 2013 Apr;24 Suppl 2:ii15-23. doi: 10.1093/annonc/mdt053. Review.

PMID:
23715939
22.

T cell receptor variable β gene repertoire in liver and peripheral blood lymphocytes of chronically hepatitis C virus-infected patients with and without mixed cryoglobulinaemia.

Russi S, Lauletta G, Serviddio G, Sansonno S, Conteduca V, Sansonno L, De Re V, Sansonno D.

Clin Exp Immunol. 2013 May;172(2):254-62. doi: 10.1111/cei.12035.

23.

Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2.

Antonelli A, Fallahi P, Ferrari SM, Corrado A, Sebastiani M, Giuggioli D, Miccoli M, Zignego AL, Sansonno D, Marchi S, Ferri C.

Clin Rheumatol. 2013 Aug;32(8):1147-54. doi: 10.1007/s10067-013-2246-y. Epub 2013 Apr 5.

PMID:
23559389
24.

High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia.

Antonelli A, Fallahi P, Ferrari SM, Frascerra S, Mancusi C, Colaci M, Manfredi A, Sansonno D, Zignego AL, Ferri C.

Int J Immunopathol Pharmacol. 2013 Jan-Mar;26(1):49-57.

PMID:
23527708
25.

H. pylori infection and gastric cancer: state of the art (review).

Conteduca V, Sansonno D, Lauletta G, Russi S, Ingravallo G, Dammacco F.

Int J Oncol. 2013 Jan;42(1):5-18. doi: 10.3892/ijo.2012.1701. Epub 2012 Nov 15. Review.

PMID:
23165522
26.

B-cell frequency in hepatitis C virus-related mixed cryoglobulinemia.

Sansonno D, Russi S, Conteduca V, Sansonno L.

Hepatology. 2013 Jul;58(1):448. doi: 10.1002/hep.26117. Epub 2013 May 27. No abstract available.

PMID:
23112004
27.

Immune-related disorders and extrahepatic diseases in chronic HCV infection.

Sansonno D.

Clin Dev Immunol. 2012;2012:509309. doi: 10.1155/2012/509309. Epub 2012 Oct 11. No abstract available.

28.

In reply.

Sansonno D, Lauletta G, Russi S, Conteduca V, Sansonno L, Dammacco F, Marano G.

Oncologist. 2012;17(9):e24-5. No abstract available.

29.

Barrett's esophagus and esophageal cancer: an overview.

Conteduca V, Sansonno D, Ingravallo G, Marangi S, Russi S, Lauletta G, Dammacco F.

Int J Oncol. 2012 Aug;41(2):414-24. doi: 10.3892/ijo.2012.1481. Epub 2012 May 17. Review.

PMID:
22615011
30.

Cytokines and HCV-related disorders.

Fallahi P, Ferri C, Ferrari SM, Corrado A, Sansonno D, Antonelli A.

Clin Dev Immunol. 2012;2012:468107. doi: 10.1155/2012/468107. Epub 2012 May 7. Review.

31.

Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis.

Quartuccio L, Isola M, Corazza L, Maset M, Monti G, Gabrielli A, Tzioufas AG, Ferri C, Ferraccioli G, Ramos-Casals M, Voulgarelis M, Lenzi M, Mascia MT, Sansonno D, Cacoub P, Tomsic M, Tavoni A, Pietrogrande M, Zignego AL, Scarpato S, Pioltelli P, Steinfeld S, Lamprecht P, Galli M, Bombardieri S, De Vita S.

Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S48-52. Epub 2012 May 14.

PMID:
22410397
32.

Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trial.

Sansonno D, Lauletta G, Russi S, Conteduca V, Sansonno L, Dammacco F.

Oncologist. 2012;17(3):359-66. doi: 10.1634/theoncologist.2011-0313. Epub 2012 Feb 14.

33.

Preliminary classification criteria for the cryoglobulinaemic vasculitis.

De Vita S, Soldano F, Isola M, Monti G, Gabrielli A, Tzioufas A, Ferri C, Ferraccioli GF, Quartuccio L, Corazza L, De Marchi G, Ramos Casals M, Voulgarelis M, Lenzi M, Saccardo F, Fraticelli P, Mascia MT, Sansonno D, Cacoub P, Tomsic M, Tavoni A, Pietrogrande M, Zignego AL, Scarpato S, Mazzaro C, Pioltelli P, Steinfeld S, Lamprecht P, Bombardieri S, Galli M.

Ann Rheum Dis. 2011 Jul;70(7):1183-90. doi: 10.1136/ard.2011.150755. Epub 2011 May 13.

34.

Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients.

Pietrogrande M, De Vita S, Zignego AL, Pioltelli P, Sansonno D, Sollima S, Atzeni F, Saccardo F, Quartuccio L, Bruno S, Bruno R, Campanini M, Candela M, Castelnovo L, Gabrielli A, Gaeta GB, Marson P, Mascia MT, Mazzaro C, Mazzotta F, Meroni P, Montecucco C, Ossi E, Piccinino F, Prati D, Puoti M, Riboldi P, Riva A, Roccatello D, Sagnelli E, Scaini P, Scarpato S, Sinico R, Taliani G, Tavoni A, Bonacci E, Renoldi P, Filippini D, Sarzi-Puttini P, Ferri C, Monti G, Galli M.

Autoimmun Rev. 2011 Jun;10(8):444-54. doi: 10.1016/j.autrev.2011.01.008. Epub 2011 Feb 15. Review.

35.

Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study.

Dammacco F, Tucci FA, Lauletta G, Gatti P, De Re V, Conteduca V, Sansonno S, Russi S, Mariggiò MA, Chironna M, Sansonno D.

Blood. 2010 Jul 22;116(3):343-53. doi: 10.1182/blood-2009-10-245878. Epub 2010 Mar 22.

PMID:
20308602
36.

N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha both are increased in patients with Hepatitis C.

Antonelli A, Ferri C, Ferrari SM, Marchi S, De Bortoli N, Sansonno D, Chiavacci C, Ferrannini E, Fallahi P.

J Interferon Cytokine Res. 2010 May;30(5):359-63. doi: 10.1089/jir.2009.0059.

PMID:
20187770
37.

Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage.

Sansonno D, Tucci FA, Ghebrehiwet B, Lauletta G, Peerschke EI, Conteduca V, Russi S, Gatti P, Sansonno L, Dammacco F.

J Immunol. 2009 Nov 1;183(9):6013-20. doi: 10.4049/jimmunol.0902038. Epub 2009 Oct 14.

38.

Clonal CD27+ CD19+ B cell expansion through inhibition of FC gammaIIR in HCV(+) cryoglobulinemic patients.

De Re V, Pavan A, Sansonno S, Sansonno D, Racanelli V.

Ann N Y Acad Sci. 2009 Sep;1173:326-33. doi: 10.1111/j.1749-6632.2009.04664.x.

PMID:
19758169
39.

Characterization of antibodies directed against the immunoglobulin light kappa chain variable chain region (VK) of hepatitis C virus-related type-II mixed cryoglobulinemia and B-cell proliferations.

de Re V, Simula MP, Pavan A, Garziera M, Marin D, Dolcetti R, de Vita S, Sansonno D, Geremia S, Toffoli G.

Ann N Y Acad Sci. 2009 Sep;1173:152-60. doi: 10.1111/j.1749-6632.2009.04677.x.

PMID:
19758144
40.

B cells and HCV: an infection model of autoimmunity.

Sansonno L, Tucci FA, Sansonno S, Lauletta G, Troiani L, Sansonno D.

Autoimmun Rev. 2009 Dec;9(2):93-4. doi: 10.1016/j.autrev.2009.03.008. Epub 2009 Mar 24. Review.

PMID:
19318140
41.

Endocrine manifestations of hepatitis C virus infection.

Antonelli A, Ferri C, Ferrari SM, Colaci M, Sansonno D, Fallahi P.

Nat Clin Pract Endocrinol Metab. 2009 Jan;5(1):26-34. doi: 10.1038/ncpendmet1027. Review.

PMID:
19079271
42.

HCV inhibits antigen processing and presentation and induces oxidative stress response in gastric mucosa.

De Re V, Simula MP, Cannizzaro R, Sansonno D, Canzonieri V, Gloghini A, Carbone A, Colombatti A, Marin MD, De Zorzi M, Toffoli G.

Proteomics Clin Appl. 2008 Sep;2(9):1290-9. doi: 10.1002/prca.200800059. Epub 2008 Jul 21.

PMID:
21136923
43.

Increased serum levels of the chemokine CXCL13 and up-regulation of its gene expression are distinctive features of HCV-related cryoglobulinemia and correlate with active cutaneous vasculitis.

Sansonno D, Tucci FA, Troiani L, Lauletta G, Montrone M, Conteduca V, Sansonno L, Dammacco F.

Blood. 2008 Sep 1;112(5):1620-7. doi: 10.1182/blood-2008-02-137455. Epub 2008 Jun 12.

PMID:
18550853
44.

Mixed cryoglobulinemia syndrome as an additional autoimmune disorder associated with risk for lymphoma development.

De Re V, De Vita S, Sansonno D, Toffoli G.

Blood. 2008 Jun 15;111(12):5760. doi: 10.1182/blood-2008-04-149567. No abstract available.

PMID:
18544704
45.

Double-filtration plasmapheresis in the treatment of leg ulcers in cryoglobulinemia.

Ramunni A, Lauletta G, Brescia P, Saliani MT, Montrone M, Chironna M, Sansonno D, Dammacco F, Coratelli P.

J Clin Apher. 2008;23(3):118-22. doi: 10.1002/jca.20166.

PMID:
18484642
46.

Current and emerging therapeutic approaches in HCV-related mixed cryoglobulinemia.

Sansonno D, Tucci FA, Troiani L, Sansonno L, Dammacco F.

Curr Med Chem. 2008;15(2):117-26. Review.

PMID:
18220767
47.

Mixed cryoglobulinemia: a model of virus-related disease in internal medicine.

Dammacco F, Lauletta G, Montrone M, Sansonno D.

Dig Liver Dis. 2007 Sep;39 Suppl 1:S8-S12. Review.

PMID:
17936230
48.

Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus.

De Re V, Caggiari L, De Vita S, Mazzaro C, Lenzi M, Galli M, Monti G, Ferri C, Zignego AL, Gabrielli A, Sansonno D, Dammacco F, Libra M, Sacchi N, Talamini R, Spina M, Cannizzaro R, Guidoboni M, Dolcetti R.

Dig Liver Dis. 2007 Sep;39 Suppl 1:S65-71.

PMID:
17936227
49.

B-cell depletion in the treatment of mixed cryoglobulinemia.

Sansonno D, Tucci FA, Montrone M, Troiani L, Sansonno L, Gatti P, Lauletta G.

Dig Liver Dis. 2007 Sep;39 Suppl 1:S116-21.

PMID:
17936212
50.

Role of the HLA class II: HCV-related disorders.

De Re V, Caggiari L, Simula MP, De Vita S, Mazzaro C, Lenzi M, Massimo GM, Monti G, Ferri C, Zignego AL, Gabrielli A, Sansonno D, Dammacco F, Libra M, Sacchi N, Talamini R, Spina M, Tirelli U, Cannizzaro R, Dolcetti R.

Ann N Y Acad Sci. 2007 Jun;1107:308-18.

PMID:
17804559

Supplemental Content

Loading ...
Support Center